Mechanistically, m6A-binding protein YTHDF1 can elevate the translation of lysosomal cathepsins in DCs, which consequently degrade the tumor antigens and suppress their antigen-presentation as well as CD8+ T cells-priming ability (Figure 5). The gene discussed is YTHDF1; the disease is neoplasm.